Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma. - Shi, Wenhao; Tang, Haotian; Tong, Linjiang; Song, Peiran; Huang, Yuqing; Wan, Zhipeng; Huang, Gege; Liu, Qiupei; Zhan, Zhengsheng; Zhou, Yu; Li, Yuantong; Wen, Jiaxin; et al. (Cancer Cell International, 2025)